Abstract
Bone scintigraphy was performed in 16 men with newly diagnosed prostatic carcinoma before orchiectomy as well as 2 weeks and 2 months after operation. The uptake in the lower thoracic and lumbar vertebrae was registered up to 240 min after injection of 99mTc-MDP and was then calculated for each patient and vertebra. The relative standard deviation in measured uptake due to measuring technique was estimated to be±7%. In eight patients, who had normal bone scintigraphies before orchiectomy, there were no changes in the uptake values after operation. The remaining eight patients had widespread metastatic involvement prior to treatment. Six of these patients showed a so called “flare phenomenon” in the abnormal vertebrae which means an initial increase in uptake after operation followed by a decreased uptake in response to therapy. One patient had a continuously increased uptake in all the abnormal vertebrae which correlated well with the clinical progression of the disease, while in another patient both reactions were seen. Thus, repeated quantitative bone scintigraphies using 99mTc-MDP can be made in a reproducible way and can be a useful tool to follow a patient's response to treatment.
Similar content being viewed by others
References
Alexander JL, Gillespie, PJ, Edelstyn GA (1976) Serial bone scanning using technetium 99m diphosphonate in patients undergoing cyclical combination chemotherapy for advanced breast cancer. Clin Nucl Med 1:13–17
Blake GM, Zivanovic MA, McEwan AJ, Ackery DM (1986) Sr-89 therapy: Strontium kinetics in disseminated carcinoma of the prostate. Eur J Nucl Med 12:447–454
Citrin DL (1977) Problems and limitations of bone scanning with the 99Tcm-phosphates. Clin Radiol 28:97–105
Drelichman A, Decker DA, Al-Sarraf M, Vaitkevicius VK, Muz J (1984) Computerized bone scan. A potentially useful technique to measure response in prostatic carcinoma. Cancer 53:1061–1065
Fitzpatrick JM, Constable AR, Sherwood T, Stephenson JJ, Chisholm GD, O'Donoghue EPN (1978) Serial bone scanning: The assessment of treatment response in carcinoma of the prostate. Br J Urol 50:555–561
Gillespie PJ, Alexander JL, Edelstyn GA (1975) Changes in 87mSr concentrations in skeletal metastases in patients responding to cyclical combination chemotherapy for advanced breast cancer. J Nucl Med 16:191–193
Hardy JG, Kulatilake AE, Wastie ML (1980) An index for monitoring bone metatases from carcinoma of the prostate. Br J Radiol 53:869–873
Hopkins SC, Nissenkorn I, Palmieri GMA, Ikard M, Moinuddin M, Soloway MS (1983) Serial spot hydroxyproline/creatinine ratios in metastatic prostatic cancer. J Urol 129:319–323
Langhammer H, Sintermann R, Hör G, Pabst HW (1978) Serial bone scintigraphy for assessing the effectiveness of treatment of osseous metastases from prostatic cancer. Nuklearmedizin 17:87–91
Levenson RM, Sauerbrunn BJL, Bates HR, Newman RD, Eddy JL, Ihde DC (1983) Comparative value of bone scintigraphy and radiography in monitoring tumor response in systemically treated prostatic carcinoma. Radiology 146:513–518
McEwan AJ, Zivanovic MA, Blake GM, Buchanan RB, Ackery DM (1986) 89Sr therapy: Clinical response in metastatic bone disease. Nucl Med Commun 7:293
Osmond JD III, Pendergrass HP, Potsaid MS (1975) Accuracy of 99mTc-diphosphonate bone scans and roentgenograms in the detection of prostate, breast and lung carcinoma metastases. Am J Roentgenol 125:972–977
Perkins AC, Hardy JG, Wastie ML, Clifford KMA (1982) Serial radionuclide imaging during treatment of patients with diffuse bone metastases from carcinoma of the prostate. Eur J Nucl Med 7:322–323
Pollen JJ, Gerber K, Ashburn WL, Schmidt JD (1981a) The value of nuclear bone imaging in advanced prostatic cancer. J Urol 125:222–223
Pollen JJ, Gerber K, Ashburn WL, Schmidt JD (1981b) Nuclear bone imaging in metastatic cancer of the prostate. Cancer 47:2585–2594
Pollen JJ, Witztum KF, Ashburn WL (1984) The flare phenomenon on radionuclide bone scan in metastatic prostate cancer. Am J Radiol 142:773–776
Robinson MRG, Constable AR (1973) Strontium-87m and the gamma camera in the study of bone metastases from carcinoma of the prostate. Br J Urol 45:173–178
Snedecor GW, Cochran WG (1980) Statistical Methods. 7th Ed. Iowa State University Press, Ames, Iowa, USA
Soloway MS, Hopkins SC (1983) Prostate cancer: Criteria of objective response to treatment. In: Carter SK, Marberger M (eds) Proceedings: 13th International Congress of Chemotherapy, Vienna, p 242/6-10
Subramanian G, McAfee JG, Blair RJ, Kallfelz FA, Thomas FD (1975) Technetium-99m-methylene diposphonate — a superior agent for skeletal imaging: Comparison with other technetium complexes. J Nucl Med 16:744–755
Williams DF, Blahd WH (1967) The diagnostic and prognostic value of strontium-85 photoscanning in carcinoma of the prostate. J Urol 97:1070–1074
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sundkvist, G.M.G., Ahlgren, L., Lilja, B. et al. Repeated quantitative bone scintigraphy in patients with prostatic carcinoma treated with orchiectomy. Eur J Nucl Med 14, 203–206 (1988). https://doi.org/10.1007/BF00257328
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00257328